QRGenetics
General Data
Reg Number
516018769
Sector
Biomed
Established
2019
No. of Employees
12
Stage
R&D
Additional Funding
1
Description
QRGenetics develop a powerful AI-supported drug discovery engine that utilizes exclusive spatial analytics and proprietary datasets, to rapidly produce novel drug-target combinations that are effective for multiple indications
Technology
A drug discovery platform, combining supercomputing analysis with Ai-based research on biological pathways for better prediction of outcomes.
Targeted Customers
Physicians, Healthcare industry, Pharma companies.
Management personnel
Shane Wald-Altman - CEO & Co-Founder
Winning details
Route name
Winning year
The Expedited Program
The Expedited Program
2024